Haem Nurse - MM focus - passionate about real world optimal drug access / outcomes for all

Sydney, New South Wales
Joined August 2022
Glasgow @profBigG delivered. Congratulations all #IMS26 @Myeloma_Society Excited to 👀all next yr at 🐘🇮🇳 Nursing & Allied Health welcome colleagues to contribute and be part of ongoing improved pt outcomes @mmamynurse @marymyeloma @Bethfaiman @domenica76 @RahulBanerjeeMD
Thank you to everyone who joined #IMS26, both in person and virtually. Save the date for next year’s meeting, taking place September 29–October 2 in New Delhi, India. We look forward to seeing you in 2027!
2
1
5
822
Thats a wrap #IMS26 PERSEUS up front SOC- BsAB come forward-fixed duration therapies-looking forward to cure-InVivoCART ahead.
1
2
532
Thats a wrap #IMS26 PERSEUS up front SOC- BsAB come forward-fixed duration therapies-looking forward to cure-InVivoCART ahead.
2
5
873
Is this you @DrRakeshPopat ?
Meet the next generation of myeloma health care professionals! #IMS26 @HealthTree
1
1
5
594
Bumped into @DrRakeshPopat @profBigG post @Myeloma_Society #IMS26 night after @chillipipers New approach to #mmsm. @RahulBanerjeeMD are you in there!?
1
2
7
512
Delighted to hear pt org panel #IMS26 mention valuable role of #nurses to outcomes of those with #mm. Thank-you to #IMS26 for ongoing support of Nursing & Allied Health Symposium - strong desire to increase length / opportunities here. @Bethfaiman @mmamynurse @marymyeloma
3
6
268
Important to see impressive work of pt groups at #IMS26 demonstrating their work to improving outcomes for those living with MM @IMFmyeloma @MyelomaUK @MyelomaEurope MMRF and @MyelomaAust_MFA
4
1
8
520
Impressive - yet Dara not universally available 🌎🌍- take NZ as example - no access to Dara in any line!! #MMsM must continue to work towards IMPROVING access so all people can benefit from increased LIFE @MyelomaNZ @LBCNZ
#IMS26 #mmsm Plenary Long term follow up PERSEUS ➡️Median follow up ~7 years Dara-RVD showed better PFS of 81% vs. 56% with better MRD negativity at both 10-5 and 10-6 sensitivity thresholds (lower numbers with high risk disease) ➡️~ 3 out of 4 DVRd-DR patients receiving maintenance achieved 12-month sustained MRD negativity, with subsequent discontinuation of daratumumab OS still not statistically different Amazing long therapy results with Quad induction, transplant and maintenance therapy
1
4
13
1,224
We should prioritize quality of life (QoL) as an endpoint in MM clinical trials, especially in high-risk patients --- Karthik Ramasamy, MD, PhD. He presented QoL data from the RADAR trial in newly diagnosed pts w/ ultra high-risk MM. #IMS26
1
3
12
428
❤️catching up with International 🇬🇧 #NAH friends at #IMS26. Collaborations @MyelomaUK @hsanz_org_au and friendships
1
6
194
Regionally appropriate 🇦🇺🐨consensus optimal delivery of BsAB @hsanz_org_au with expert Int review from 🇺🇸 @IMFmyeloma @Bethfaiman @marymyeloma Sam Shenoy
BsAB in OP setting supported by careful pt selection, CRS mitigation and immune surveillance/prophylaxis. Thanks Landgren/Seymour/Kowalski/Hankey for session #IMS26 See poster NSP-06 today @hsanz_org_au for 🇦🇺🦘consensus @marymyeloma @Bethfaiman
7
223
Could this be the new target for 🏴󠁧󠁢󠁳󠁣󠁴󠁿#mmsm therapy - Girders against MM? #downwithdex #upwithirnbru @RahulBanerjeeMD @Bethfaiman @profBigG @DrRakeshPopat @marymyeloma @mmamynurse
1
2
7
265
BsAB in OP setting supported by careful pt selection, CRS mitigation and immune surveillance/prophylaxis. Thanks Landgren/Seymour/Kowalski/Hankey for session #IMS26 See poster NSP-06 today @hsanz_org_au for 🇦🇺🦘consensus @marymyeloma @Bethfaiman
1
2
1
5
408
Nice work from @DrRakeshPopat and UK Myeloma Society ProMMise D trial testing use of PROM tool VRAT to assess ocular toxicity in #BelMaf and potential to avoid formal ocular exams.
4
6
253
Congratulations to Grace Reins and Huntsman Cancer Centre colleagues @marymyeloma for winning inaugural Best Abstract Award at #IMS26 NAH 🥇Project ECHO - Building Specialty Capacity in Rural Health - readily translatable @mmamynurse @Bethfaiman
2
7
309
Don’t forget your passport! ✈️🌎Everything you need to know before heading to Glasgow can be found here➡️ow.ly/izUW50ZPIYj
4
5
448
Very important work - applicable to 🌏especially those of us 🇦🇺🦘with few ATCs, vast land mass (larger than USA) & large areas with low pop. More of this please Blue et al and my USA buddies @RahulBanerjeeMD @Bethfaiman @domenica76 and @marymyeloma I 👀your challenges!
Blue et al, now in CLML: Modern analysis of 🇺🇸 access to CAR-T in myeloma... we still have work to do. I'm proud to have cared for so many Alaska / northern Idaho / Montana patients amidst their CAR-T journeys, but some day I hope they can come to Seattle for other reasons!
1
2
3
815
…..and don’t get me started on our cousin 🇳🇿@MyelomaNZ @LBCNZ significant challenges in accessing even SOC drugs for #MMs - this needs to change now. Thanks for ongoing hard work @MyelomaAmarc @ALLGtrials @IMFmyeloma @MyelomaAust_MFA
1
2
4
299
3% of Australians donate 🩸🩸in Australia - 14th June is World Blood Donor. Please consider donating as able - its a small step in your day - but helps save lives. @SydneyLHD TeamHaem dropped off a few pints yesterday @lifebloodau Marrickville
2
1
3
76